Avanos Medical (AVNS) Interest Coverage Ratio Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.96% |
| Dec 31, 2025 | 15.72% |
| Sep 30, 2025 | 34.42% |
| Jun 30, 2025 | -145.39% |
| Mar 31, 2025 | 103.79% |
| Dec 31, 2024 | -188.78% |
| Sep 30, 2024 | 22.20% |
| Jun 30, 2024 | 22.21% |
| Mar 31, 2024 | 17.02% |
| Dec 31, 2023 | 27.96% |
| Sep 30, 2023 | -31.29% |
| Jun 30, 2023 | -21.75% |
| Mar 31, 2023 | -16.98% |
| Dec 31, 2022 | 76.11% |
| Sep 30, 2022 | 39.71% |
| Jun 30, 2022 | 34.56% |
| Mar 31, 2022 | 37.17% |
| Dec 31, 2021 | -7.45% |
| Sep 30, 2021 | 8.71% |
| Jun 30, 2021 | -42.25% |
| Mar 31, 2021 | -41.87% |
| Dec 31, 2020 | -20.49% |
| Sep 30, 2020 | 79.16% |
| Jun 30, 2020 | -16.74% |
| Mar 31, 2020 | -50.98% |
| Dec 31, 2019 | -16.90% |
| Sep 30, 2019 | -15.32% |
| Dec 31, 2018 | 66.66% |